
Currently, there is no treatment standard for patients with locally advanced pancreatic cancer zzso after zzso The aim of the present study was to zzso assess overall survival and toxicity of chemotherapy in addition to zzso in this patient zzso 

zzso zzso zzso to the primary tumor zzso zzso and the zzso zzso zzso was combined with zzso or zzso chemotherapy followed by additional chemotherapy with zzso until progression or no further zzso zzso for chemotherapy was taken at the discretion of the attending physician considering the patient's zzso 

A total of zzso patients were addressed to the local tumor zzso Patients with zzso treatment or zzso disease were excluded zzso zzso zzso 82 patients were treated with zzso and had additional chemotherapy zzso zzso 40) or no further treatment zzso zzso zzso zzso of the two groups were equally zzso Patients with chemotherapy had significantly longer overall survival as compared to patients without (13 months zzso 8 zzso p zzso zzso median survival zzso zzso months for all zzso Acute toxicity of maintenance chemotherapy was relatively zzso 

Maintenance chemotherapy after zzso for patients with locally advanced zzso may significantly increase survival rates without severe side effects and is therefore recommended as standard treatment following zzso 

